Abstract

Inflammation and hypercoagulability predispose to atherothrombosis and seem to be important features of the metabolic syndrome. The most convincing evidence is the association with increased levels of C-reactive protein. The hemostatic abnormality that has been most consistently associated with insulin resistance is an elevated plasminogen activator inhibitor-1 level. In contrast, markers of hypercoagulability have been associated inconsistently with hyperinsulinemia and glucose intolerance. Fibrinogen clusters with inflammatory factors, which suggests involvement of adipose tissue-generated inflammatory cytokines. Elevated von Willebrand's factor and factor VIII levels aggregate with indicators of endothelial injury,whereas vitamin K-dependent coagulation proteins correlate with triglyceride levels.

Keywords

MedicineInternal medicineInflammationFibrinogenEndocrinologyInsulin resistanceVon Willebrand factorHyperinsulinemiaPlasminogen activatorMetabolic syndromeDiabetes mellitusInsulinPlatelet

MeSH Terms

Blood Coagulation DisordersHumansInflammationMetabolic Syndrome

Affiliated Institutions

Related Publications

Publication Info

Year
2004
Type
review
Volume
33
Issue
2
Pages
431-453
Citations
142
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

142
OpenAlex
2
Influential
100
CrossRef

Cite This

Sridevi Devaraj, Robert S. Rosenson, Ishwarlal Jialal (2004). Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. Endocrinology and Metabolism Clinics of North America , 33 (2) , 431-453. https://doi.org/10.1016/j.ecl.2004.03.008

Identifiers

DOI
10.1016/j.ecl.2004.03.008
PMID
15158528

Data Quality

Data completeness: 81%